2,6-Dichloro-3-(trifluoromethyl)aniline is an organic compound characterized by the presence of an aniline structure substituted with two chlorine atoms and a trifluoromethyl group. Its molecular formula is C8H5Cl2F3N, indicating a complex arrangement of halogen and nitrogen functionalities. The compound typically appears as a solid at room temperature and is known for its relatively low solubility in water, while being more soluble in organic solvents. It exhibits properties such as moderate stability under standard conditions, but may undergo reactions typical of aniline derivatives, including electrophilic aromatic substitution. The presence of the trifluoromethyl group enhances its lipophilicity and can influence its reactivity and biological activity. This compound is of interest in various fields, including agrochemicals and pharmaceuticals, due to its potential applications as a building block in the synthesis of more complex molecules. Safety precautions should be observed when handling this substance, as it may pose health risks, including toxicity and environmental hazards.

2,6-dichloro-3-(trifluoromethyl)aniline

6656-72-0: 2,6-Dichloro-3-(trifluoromethyl)benzenamine, 2,6-Dichloro-α,α,α-trifluoro-m-toluidine, 6656-72-0, Benzenamine, 2,6-dichloro-3-(trifluoromethyl)-, Zr Bg Fg Cxfff, 2,6-Dichloro-3-(trifluoromethyl)aniline

2,6-DICHLORO-3-TRIFLUOROMETHYL ANILINE

2,6-Dichloro-3-(trifluoromethyl)aniline

2,6-Dichloro-3-(Trifluoromethyl)Aniline is a pyrimidine derivative that is used as a nitrogen source in the synthesis of various organic compounds. It is also used to inhibit nitrification and sulfonamides, which are chemicals that inhibit the growth of bacteria. 2,6-Dichloro-3-(Trifluoromethyl)Aniline has been shown to be effective against anaerobic bacteria such as Clostridium tetani and Clostridium perfringens.
2,6-Dichloro-3-(Trifluoromethyl)Aniline inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using a patch-clamp technique on human erythrocytes. This active form is metabolized through a number of metabolic transformations, including hydrolysis

CAS 6656-72-0: 2,6-dichloro-3-(trifluoromethyl)aniline

2,6-DICHLORO-3-TRIFLUOROMETHYL ANILINE

Ref: IN-DA00FF8T

2,6-Dichloro-3-(trifluoromethyl)aniline

Ref: 10-F343007

2,6-Dichloro-3-(trifluoromethyl)aniline

Ref: 54-PC302015

2,6-Dichloro-3-(Trifluoromethyl)Aniline

Ref: 3D-FD84808